Please assess the completion status of the following clinical trial:

Trial Title: Effect of Two Versus Three Pneumococcal Conjugate Vaccinations

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE3
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Newborn infants eligible for participation in the national infant vaccination program in the Netherlands~Exclusion Criteria:~exclusion from the national vaccination program because of the presence of~* a medical condition requiring treatment that can interfere with the effect of vaccinations~* known or suspected allergy to components of the pneumococcal conjugate vaccine~* known or suspected immunodeficiency disease~* previous treatment with plasma or immunoglobulins~* previous vaccinations other than hepatitis B vaccinations~* coagulation disorders

- Gender: ALL
- Minimum Age: 2 Months
- Maximum Age: 3 Months
- Healthy Volunteers: t

Study Arms:
- 2-dose (Type: EXPERIMENTAL): PCV7 at age 2 and 4 months
- 2+1-dose (Type: EXPERIMENTAL): PCV7 at age 2, 4 and 11 months
- Control (Type: NO_INTERVENTION): Control group

Based on this trial design, predict the completion outcome and termination type (if applicable).